Literature DB >> 26476085

Association Analysis of FOXO3 Longevity Variants With Blood Pressure and Essential Hypertension.

Brian J Morris, Randi Chen1, Timothy A Donlon1, Daniel S Evans2, Gregory J Tranah2, Neeta Parimi2, Georg B Ehret3, Christopher Newton-Cheh4, Todd Seto5, D Craig Willcox6,7,8, Kamal H Masaki6,7, Kei Kamide9,10, Hirochika Ryuno9, Ryosuke Oguro11, Chikako Nakama11, Mai Kabayama9, Koichi Yamamoto11, Ken Sugimoto11, Kazunori Ikebe12, Yukie Masui13, Yasumichi Arai14, Tatsuro Ishizaki13, Yasuyuki Gondo15, Hiromi Rakugi11, Bradley J Willcox6,7.   

Abstract

BACKGROUND: The minor alleles of 3 FOXO3 single nucleotide polymorphisms (SNPs)- rs2802292 , rs2253310 , and rs2802288 -are associated with human longevity. The aim of the present study was to test these SNPs for association with blood pressure (BP) and essential hypertension (EHT).
METHODS: In a primary study involving Americans of Japanese ancestry drawn from the Family Blood Pressure Program II we genotyped 411 female and 432 male subjects aged 40-79 years and tested for statistical association by contingency table analysis and generalized linear models that included logistic regression adjusting for sibling correlation in the data set. Replication of rs2802292 with EHT was attempted in Japanese SONIC study subjects and of each SNP in a meta-analysis of genome-wide association studies of BP in individuals of European ancestry.
RESULTS: In Americans of Japanese ancestry, women homozygous for the longevity-associated (minor) allele of each FOXO3 SNP had 6mm Hg lower systolic BP and 3mm Hg lower diastolic BP compared with major allele homozygotes (Bonferroni corrected P < 0.05 and >0.05, respectively). Frequencies of minor allele homozygotes were 3.3-3.9% in women with EHT compared with 9.5-9.6% in normotensive women ( P = 0.03-0.04; haplotype analysis P = 0.0002). No association with BP or EHT was evident in males. An association with EHT was seen for the minor allele of rs2802292 in the Japanese SONIC cohort ( P = 0.03), while in European subjects the minor allele of each SNP was associated with higher systolic and diastolic BP.
CONCLUSION: Longevity-associated FOXO3 variants may be associated with lower BP and EHT in Japanese women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26476085      PMCID: PMC5055732          DOI: 10.1093/ajh/hpv171

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  47 in total

1.  Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP).

Authors: 
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

2.  Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney.

Authors:  Shinji Kume; Takashi Uzu; Kihachiro Horiike; Masami Chin-Kanasaki; Keiji Isshiki; Shin-Ichi Araki; Toshiro Sugimoto; Masakazu Haneda; Atsunori Kashiwagi; Daisuke Koya
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

3.  Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia.

Authors:  Md Ruhul Abid; Kiichiro Yano; Shaodong Guo; Virendra I Patel; Gautam Shrikhande; Katherine C Spokes; Christiane Ferran; William C Aird
Journal:  J Biol Chem       Date:  2005-06-15       Impact factor: 5.157

4.  SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap.

Authors:  Andrew D Johnson; Robert E Handsaker; Sara L Pulit; Marcia M Nizzari; Christopher J O'Donnell; Paul I W de Bakker
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

5.  GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy.

Authors:  Linda Broer; Aron S Buchman; Joris Deelen; Daniel S Evans; Jessica D Faul; Kathryn L Lunetta; Paola Sebastiani; Jennifer A Smith; Albert V Smith; Toshiko Tanaka; Lei Yu; Alice M Arnold; Thor Aspelund; Emelia J Benjamin; Philip L De Jager; Gudny Eirkisdottir; Denis A Evans; Melissa E Garcia; Albert Hofman; Robert C Kaplan; Sharon L R Kardia; Douglas P Kiel; Ben A Oostra; Eric S Orwoll; Neeta Parimi; Bruce M Psaty; Fernando Rivadeneira; Jerome I Rotter; Sudha Seshadri; Andrew Singleton; Henning Tiemeier; André G Uitterlinden; Wei Zhao; Stefania Bandinelli; David A Bennett; Luigi Ferrucci; Vilmundur Gudnason; Tamara B Harris; David Karasik; Lenore J Launer; Thomas T Perls; P Eline Slagboom; Gregory J Tranah; David R Weir; Anne B Newman; Cornelia M van Duijn; Joanne M Murabito
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-09-08       Impact factor: 6.053

Review 6.  A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer.

Authors:  Brian J Morris
Journal:  J Hypertens       Date:  2005-07       Impact factor: 4.844

7.  Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus.

Authors:  Jayesh Kumar Bhatt; Sabin Thomas; Moola Joghee Nanjan
Journal:  Nutr Res       Date:  2012-07-27       Impact factor: 3.315

8.  FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts.

Authors:  Calin B Chiribau; Lihong Cheng; Ioan C Cucoranu; Yong-Shen Yu; Roza E Clempus; Dan Sorescu
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

9.  Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.

Authors:  Hui-Hua Li; Monte S Willis; Pamela Lockyer; Nathaniel Miller; Holly McDonough; David J Glass; Cam Patterson
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis.

Authors:  Ji-Ming Bao; Xian-Lu Song; Ying-Qia Hong; Hai-Li Zhu; Cui Li; Tao Zhang; Wei Chen; Shan-Chao Zhao; Qing Chen
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

View more
  9 in total

Review 1.  FOXO1: Another avenue for treating digestive malignancy?

Authors:  Feiyu Shi; Tian Li; Zhi Liu; Kai Qu; Chengxin Shi; Yaguang Li; Qian Qin; Liang Cheng; Xin Jin; Tianyu Yu; Wencheng Di; Jianwen Que; Hongping Xia; Junjun She
Journal:  Semin Cancer Biol       Date:  2017-09-28       Impact factor: 15.707

2.  Longevity-Associated FOXO3 Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations.

Authors:  Bradley J Willcox; Brian J Morris; Gregory J Tranah; Randi Chen; Kamal H Masaki; Qimei He; D Craig Willcox; Richard C Allsopp; Stefan Moisyadi; Mariana Gerschenson; Philip M C Davy; Leonard W Poon; Beatriz Rodriguez; Anne B Newman; Tamara B Harris; Steven R Cummings; Yongmei Liu; Neeta Parimi; Daniel S Evans; Timothy A Donlon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-05-01       Impact factor: 6.053

Review 3.  FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin Hubs.

Authors:  Paola Sanese; Giovanna Forte; Vittoria Disciglio; Valentina Grossi; Cristiano Simone
Journal:  Comput Struct Biotechnol J       Date:  2019-06-13       Impact factor: 7.271

4.  FOXO3 longevity genotype mitigates the increased mortality risk in men with a cardiometabolic disease.

Authors:  Randi Chen; Brian J Morris; Timothy A Donlon; Kamal H Masaki; D Craig Willcox; Philip M C Davy; Richard C Allsopp; Bradley J Willcox
Journal:  Aging (Albany NY)       Date:  2020-12-01       Impact factor: 5.682

Review 5.  Longevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases.

Authors:  Yan Zhao; You-Shuo Liu
Journal:  Front Cardiovasc Med       Date:  2021-12-23

6.  No Association Between a Genetic Variant of FOXO3 and Risk of Type 2 Diabetes Mellitus in the Elderly Population of North India.

Authors:  Sartaj Hussain; Kanak Lata Dwivedi; Suraj Singh Yadav; Kauser Usman; Rajendra Nath; Sanjay Khattri
Journal:  Indian J Clin Biochem       Date:  2020-08-10

7.  The FoxO3 gene and cause-specific mortality.

Authors:  Bradley J Willcox; Gregory J Tranah; Randi Chen; Brian J Morris; Kamal H Masaki; Qimei He; D Craig Willcox; Richard C Allsopp; Stefan Moisyadi; Leonard W Poon; Beatriz Rodriguez; Anne B Newman; Tamara B Harris; Steven R Cummings; Yongmei Liu; Neeta Parimi; Daniel S Evans; Phil Davy; Mariana Gerschenson; Timothy A Donlon
Journal:  Aging Cell       Date:  2016-04-13       Impact factor: 9.304

Review 8.  Recent advances in understanding the role of FOXO3.

Authors:  Renae J Stefanetti; Sarah Voisin; Aaron Russell; Séverine Lamon
Journal:  F1000Res       Date:  2018-08-31

9.  The Association Between Longevity-Associated FOXO3 Allele and Heart Disease in Septuagenarians and Octogenarians: The SONIC Study.

Authors:  Nonglak Klinpudtan; Richard C Allsopp; Mai Kabayama; Kayo Godai; Yasuyuki Gondo; Yukie Masui; Yuya Akagi; Werayuth Srithumsuk; Ken Sugimoto; Hiroshi Akasaka; Yoichi Takami; Yasushi Takeya; Koichi Yamamoto; Kazunori Ikebe; Saori Yasumoto; Madoka Ogawa; Tatsuro Ishizaki; Yasumichi Arai; Hiromi Rakugi; Randi Chen; Bradley J Willcox; D Craig Willcox; Kei Kamide
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-08-12       Impact factor: 6.591

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.